Wednesday, November 25, 2009, 8:11am EST - Canadian Markets open in 1 hour and 19 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Savient Pharmaceuticals, Inc. (SVNT)

On Nov 24: 13.25 USD   0.00 (0.00%)  
MORE ON SVNT
Quotes
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
HereIncome Statement
Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
PERIOD ENDING 30-Sep-09 30-Jun-09 31-Mar-09 31-Dec-08
Total Revenue 328   680   1,088   1,098  
Cost of Revenue 374   372   491   299  
Gross Profit (46) 308   597   799  
Operating Expenses
Research Development 17,670   11,638   12,763   17,726  
Selling General and Administrative 8,538   7,397   9,468   8,273  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (26,254) (18,727) (21,634) (25,200)
Income from Continuing Operations
Total Other Income/Expenses Net 12,314   (36,082) (315) (491)
Earnings Before Interest And Taxes (13,940) (54,809) (21,949) (25,691)
Interest Expense -   -   -   -  
Income Before Tax (13,940) (54,809) (21,949) (25,691)
Income Tax Expense (64) -   -   (1,344)
Minority Interest -   -   -   -  
Net Income From Continuing Ops (13,876) (54,809) (21,949) (24,347)
Non-recurring Events
Discontinued Operations -   -   -   142  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (13,876) (54,809) (21,949) (24,205)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares ($13,876) ($54,809) ($21,949) ($24,205)

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Income Statement for Another Symbol:
Symbol Lookup
Latest News Canadian Indices


Reuters offers more in-depth Company Research , Stock Screening , and Risk Alerts on over 10,000 U.S. Equities.